Preventive treatment with the calcitonin gene-related peptide (CGRP) receptor monoclonal antibody erenumab for 6 weeks was not associated with significant reductions in weekly headache attacks, pain ...

Compared with placebo, eptinezumab failed to significantly reduce the number of episodic cluster headache (ECH) attacks but showed higher responder rates and improved quality-of-life measures. "Among ...

Please provide your email address to receive an email when new articles are posted on . Approximately one in 1,000 people have cluster headaches. Cluster headaches are nicknamed “suicide headaches” ...

Prednisone is a corticosteroid that’s commonly used across a wide range of medical specialties for its anti-inflammatory properties. In neurology, it has emerged as a therapeutic option for the acute ...

What if you could zap away the pain of a migraine or cluster headache attack with a device that fits in your hand? It’s not a gadget from a comic book — it’s gammaCore ® (nVNS), a noninvasive vagus ...

“CHs are really bad. They are one kind of pain. This is because of what happens in the brain,” he explains. “They happen because of a problem in the part of the brain called the hypothalamus. This ...